Why the study?
Does External whole-body oscillating Acceleration Synchronized with the Electrocardiogram (EASE) modify cardiac function in chronically instrumented dogs?
Does External whole-body oscillating Acceleration Synchronized with the Electrocardiogram (EASE) modify cardiac function in chronically instrumented dogs?
Synchronized external whole-body oscillating acceleration can significantly modify cardiovascular hemodynamics depending on the timing of the applied force, suggesting potential diagnostic or therapeutic applications.
The sensitivity of selected cardiovascular (CV) responses to the physical stressor of External whole-body oscillating Acceleration Synchronized with the Electrocardiogram (EASE) was analyzed in 8 chronically instrumented tranquilized dogs. A sinusoidal acceleration wave form was imposed on the supine animals along the spinal (+/- Gz) axis at a constant amplitude of +/- 0.75 G, and a frequency equal to the paced-heart frequency (2--3 Hz). When the peak force was positive in early systole, and negative in early diastole, changes in myocardial oxygen consumption (MVo2, + 8%), mean coronary flow (MCF, + 8%), stroke volume (SV, + 15%), cardiac work (CW, + 19%) and the time derivative of left ventricular pressure (dP/dt, + 18%) were minimal in comparison to nonoscillatory control values. When the peak force was positive in early diastole and negative in late diastole and early systole, changes in MVo2 (+ 41%), MCF (+ 39%), SV (+ 33%), CW (+ 50%), and dP/dt (+ 31%) were maximal. Thus the capability of EASE to produce a range of desired sustained CV responses provides a basis for its potential diagnostic/therapeutic applications.
No takes yet. Share an insight, caveat, or question.
Bhattacharya et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: